Journal
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS
Volume 9, Issue 5, Pages 368-376Publisher
SPRINGER
DOI: 10.1007/s11910-009-0054-1
Keywords
-
Categories
Funding
- NIA NIH HHS [P50 AG005138] Funding Source: Medline
Ask authors/readers for more resources
With the aging of the population, the incidence and prevalence of Alzheimer's disease will grow, increasing the burden on individuals and society. While ameliorating symptoms, the currently available treatments approved by the US Food and Drug Administration do not halt progression or cure the illness. This article discusses recent data on treatment strategies targeting amyloid and tau pathology. Novel therapeutic strategies such as inhibitors of receptors for advanced glycation end products (RAGE), potential mitochondrial modification with Dimebon, anti-inflammatory approaches, and cholesterol-lowering agents are also reviewed. An update on results from pharmacologic and nonpharmacologic prevention trials is provided.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available